This shows that DCs loaded with either tumor lysate or any of the EpiTCer bead concentrations do not react to the healthy cells investigated, indicating that the established stimulation method to enhance tumor-specific CD8+ T cells from the blood could potentially be used for adoptive cell therapy. This evidence concerns the gene CD8A and neoplasm.